<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> induces Ca(2+) influx into neuronal cells, and activates several proteases including calpains </plain></SENT>
<SENT sid="1" pm="."><plain>Since calpains play important roles in neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo>, calpain inhibitors may have potential as drugs for <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>((1S)-1((((1S)-1-<z:chebi fb="0" ids="22744">Benzyl</z:chebi>-3- cyclopropylamino-2,3-di-oxopropyl)amino)<z:chebi fb="1" ids="23019">carbonyl</z:chebi>)-3-methylbutyl) <z:chebi fb="0" ids="28616">carbamic acid</z:chebi> 5-<z:chebi fb="8" ids="32772">methoxy</z:chebi>-3-oxapentyl <z:chebi fb="21" ids="35701">ester</z:chebi> (SNJ-1945) is a novel calpain inhibitor that has good membrane permeability and water solubility </plain></SENT>
<SENT sid="3" pm="."><plain>We evaluated the effect of SNJ-1945 on the focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) in mice </plain></SENT>
<SENT sid="4" pm="."><plain>Brain damage was evaluated by assessing neurological deficits at 24 h or 72 h after MCAO and also by examining 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC) staining and terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick-end labeling (TUNEL) staining of brain sections </plain></SENT>
<SENT sid="5" pm="."><plain>When injected at 1 h after MCAO, SNJ-1945 at 30 and 100 mg/kg, i.p. decreased the infarction volume and improved the neurological deficits each assessed at 24 h </plain></SENT>
<SENT sid="6" pm="."><plain>SNJ-1945 at 100 mg/kg, i.p. also showed neuroprotective effects at 72 h and reduced the number of TUNEL-positive cells at 24 h </plain></SENT>
<SENT sid="7" pm="."><plain>SNJ-1945 was able to prevent neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> even when it was injected at up to 6 h, but not at 8 h, after MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, SNJ-1945 decreased cleaved alpha-spectrin at 6 h and 12 h, and active caspase-3 at 12 h and 24 h in ischemic brain hemisphere </plain></SENT>
<SENT sid="9" pm="."><plain>These findings indicate that SNJ-1945 inhibits the activation of calpain, and offers neuroprotection against the effects of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in mice even when given up to 6 h after MCAO </plain></SENT>
<SENT sid="10" pm="."><plain>SNJ-1945 may therefore be a potential drug for <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>